Industries

Biotechnology

Why Cooley

Breakthroughs happen with Cooley. At Cooley, we don’t just advise – we accelerate your achievements. Our collaborative approach draws upon unparalleled experience and our extensive industry network to drive strategic solutions and resolve challenges. With Cooley as your catalyst, you’re not just part of the biotech industry – you’re shaping it. 

Cooley works with biotechnology companies through all stages of the business life cycle. Our experience stretches across public offerings, mergers and acquisitions, private financings, licensing, regulatory and patent counseling. Clients that partner with us get the advantage of decades of experience, seamless teamwork and an entrepreneurial culture that help build businesses and transform breakthrough ideas into successful companies.

When it comes to biotech, Cooley was there from the start. We incorporated Genentech, the first biotech company, in 1976 and worked on Amgen’s initial public offering in 1980, the first biotech IPO in history. Enter the 21st century, where Cooley remains the preeminent law firm for disruptive biotech companies and investors, leveraging our deep industry experience to provide innovative legal solutions for our clients.

Representative matters